They (Janice Shell and pals) are confirmed liars. Who else

New Post Public Reply Private Reply Replies (0) Message Board
adirondackhi vegasandre #20615
They (Janice Shell and pals) are confirmed liars. Who else but liars would say they were surprised that Jerry followed through with his promise to file form 10 for uplisting? He's followed through with all of his projections except the timing for release of alcohol containing product due to red tape mainly, but it's still coming. The other delays were the fault of others, except for changes made to share structure involving Meadows, but we should all be thankful for that smart move. Delays do not constitute dishonesty where start ups are concerned anyhow. They are par for the course, and so far this company's wheelhouse has shown amazing progress building a kick ass brand in a market poised for explosion. Those bashing idiots have nothing credible left to say, but they're more than willing to sling shit around as soon as the news wires have cooled for a bit. To hell with them. Nothing but lies behind their "what if" BS. RMHB is a STRONG BUY. I will continue to add shares to my position. They're not shaking mine loose!

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investment Insights: Primoris Services Earnings Outlook

Updated Category News Views 130

Understanding Primoris Services Earnings Report Expectations Primoris Services (NASDAQ: PRIM) is set to unveil its quarterly earnings report. This upcoming release is being closely monitored by investors, eager to gauge the company's financial health and future guidance. Analysts are optimistic about Primoris Services, projecting an earnings per share (EPS) of $1.32 for...

Continue Reading
Evolent Health's Valuation Insights and Growth Potential Explored

Updated Category News Views 156

Evolent Health's Stock Valuation Insights Barclays reaffirmed its Overweight rating with a price target of $39.00 for Evolent Health (NYSE: EVH) recently. This kind of optimism signals that the company's specialty care management model is no ordinary player—it’s resilient in a world where value-based care (VBC) contracting strategies are all the rage in healthcare....

Continue Reading
JOYY's Impressive Third Quarter Growth Highlights Success

Updated Category News Views 250

JOYY Reports Significant Financial Growth in Third Quarter 2025 SINGAPORE — JOYY Inc. (NASDAQ: JOYY), a leading global technology company, has announced impressive financial results for the third quarter of 2025. The report highlights a notable increase in revenue, indicating the company's strong market position and growth trajectory. Strong Revenue Performance In the...

Continue Reading
Muinmos Earns Esteemed Award for KYC Solutions Excellence

Updated Category News Views 196

Muinmos Shines at Global Forex Awards Muinmos has achieved a remarkable feat by being recognized as the Best KYC Provider at the prestigious B2B Global Forex Awards. This accolade marks the company's third consecutive victory in this category, affirming its status as a leader in client onboarding technology. The award is a testament to Muinmos’ commitment to delivering...

Continue Reading
Beverly Hills Flourishes with New Luxury Attractions and Events

Updated Category News Views 384

Exciting Transformations in Beverly Hills for 2026 Beverly Hills is stepping into a vibrant era as it gears up for a significant year. Known for its glamour and global reputation, the city is enhancing its allure through newly opened hotels, restaurants, and cultural experiences. These developments underscore its position as a premier destination, attracting luxury brands...

Continue Reading